MRUS – merus n.v. - common shares (US:NASDAQ)

News

Merus (NASDAQ: MRUS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $73.00 price target on the stock.
Merus (NASDAQ: MRUS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $85.00 price target on the stock.
Merus to Present at Upcoming Investor Conferences [Yahoo! Finance]
Merus to Present at Upcoming Investor Conferences
Merus Receives FDA extension of PDUFA for zenocutuzumab
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com